{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:56:41Z","timestamp":1795190201442,"version":"4.10.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K11440"],"award-info":[{"award-number":["JP19K11440"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008889","name":"Ube Industries, Ltd. | Ube Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0525026"],"award-info":[{"award-number":["JP21wm0525026"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20lm0203007"],"award-info":[{"award-number":["JP20lm0203007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kurata Grants from the Hitachi Global Foundation, Tokyo, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ketamine, an\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-D-aspartate receptor antagonist, exerts rapid and sustained antidepressant actions. Preclinical studies demonstrated that the release of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor in the medial prefrontal cortex (mPFC) is essential for the antidepressant-like effects of ketamine. However, the role of other neurotrophic factors in the antidepressant-like effects of ketamine has not been fully investigated. Since the intra-mPFC infusion of insulin-like growth factor 1 (IGF-1) reportedly produced antidepressant-like effects, the present study examined the role of endogenous intra-mPFC IGF-1 signaling in the antidepressant-like actions of ketamine. In vivo microdialysis showed that ketamine (10 and 30\u2009mg\/kg) significantly increased extracellular IGF-1 levels in the mPFC of male C57BL\/6J mice for at least 5\u2009h. Infusion of an IGF-1 neutralizing antibody (nAb; 160\u2009ng\/side) into the mPFC 15\u2009min before or 2\u2009h after ketamine injection blocked the antidepressant-like effects of ketamine in three different behavioral paradigms (forced swim, female urine sniffing, and novelty-suppressed feeding tests were conducted 1, 3 and 4 days post-ketamine, respectively). The ketamine-like antidepressant-like actions of the intra-mPFC infusion of BDNF (100\u2009ng\/side) and IGF-1 (50\u2009ng\/side) respectively were not blocked by co-infused IGF-1 nAb and BDNF nAb (200\u2009ng\/side). Moreover, intra-mPFC infusion of IGF-1 nAb 2\u2009h post-ketamine blocked the antidepressant-like effects of ketamine in a murine lipopolysaccharide (LPS)-induced depression model. Intra-mPFC IGF-1 infusion also produced antidepressant-like effects in the LPS-challenged mice via mechanistic target of rapamycin complex 1 activation. These results suggest that persistent release of IGF-1, independently of BDNF, in the mPFC is essential for the antidepressant-like actions of ketamine.\n                  <\/jats:p>","DOI":"10.1038\/s41398-022-01943-9","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:03:12Z","timestamp":1652727792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-9746","authenticated-orcid":false,"given":"Satoshi","family":"Deyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3220-9859","authenticated-orcid":false,"given":"Makoto","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-9275","authenticated-orcid":false,"given":"Katsuyuki","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"1943_CR1","unstructured":"World Health Organization. Depression fact sheets. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression\/. Accessed 18 November 2021 (2021)."},{"key":"1943_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155\u201362.","journal-title":"J Clin Psychiatry"},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28\u201340.","journal-title":"Am J Psychiatry"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jad.2021.03.073","volume":"290","author":"K Heerlein","year":"2021","unstructured":"Heerlein K, Perugi G, Otte C, Frodl T, Degraeve G, Hagedoorn W, et al. Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes. J Affect Disord. 2021;290:334\u201344.","journal-title":"J Affect Disord"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr.","year":"2006","unstructured":"Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science."},{"key":"1943_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","volume":"69","author":"N Li","year":"2011","unstructured":"Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011;69:754\u201361.","journal-title":"Biol Psychiatry"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"172837","DOI":"10.1016\/j.pbb.2019.172837","volume":"188","author":"S Deyama","year":"2020","unstructured":"Deyama S, Duman RS. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharm Biochem Behav. 2020;188:172837.","journal-title":"Pharm Biochem Behav"},{"key":"1943_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","volume":"71","author":"RJ Liu","year":"2012","unstructured":"Liu RJ, Lee FS, Li XY, Bambico F, Duman RS, Aghajanian GK. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry. 2012;71:996\u20131005.","journal-title":"Biol Psychiatry"},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2014","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol. 2014;18:pyu033.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1176\/appi.ajp.2018.17121368","volume":"176","author":"S Deyama","year":"2019","unstructured":"Deyama S, Bang E, Wohleb ES, Li XY, Kato T, Gerhard DM, et al. Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine. Am J Psychiatry. 2019;176:388\u2013400.","journal-title":"Am J Psychiatry"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ejn.14630","volume":"53","author":"RS Duman","year":"2021","unstructured":"Duman RS, Deyama S, Fogaca MV. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci. 2021;53:126\u201339.","journal-title":"Eur J Neurosci"},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","volume":"6","author":"ND Aberg","year":"2006","unstructured":"Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJ. 2006;6:53\u201380.","journal-title":"ScientificWorldJ."},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"pyv101","DOI":"10.1093\/ijnp\/pyv101","volume":"19","author":"J Burgdorf","year":"2015","unstructured":"Burgdorf J, Zhang XL, Colechio EM, Ghoreishi-Haack N, Gross A, Kroes RA, et al. Insulin-like growth factor I produces an antidepressant-like effect and elicits N-methyl-D-aspartate receptor independent long-term potentiation of synaptic transmission in medial prefrontal cortex and hippocampus. Int J Neuropsychopharmacol. 2015;19:pyv101.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","volume":"1037","author":"BA Hoshaw","year":"2005","unstructured":"Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005;1037:204\u20138.","journal-title":"Brain Res"},{"key":"1943_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-12","volume":"8","author":"SE Park","year":"2011","unstructured":"Park SE, Dantzer R, Kelley KW, McCusker RH. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation. 2011;8:12.","journal-title":"J Neuroinflammation"},{"key":"1943_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-179","volume":"8","author":"SE Park","year":"2011","unstructured":"Park SE, Lawson M, Dantzer R, Kelley KW, McCusker RH. Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. J Neuroinflammation. 2011;8:179.","journal-title":"J Neuroinflammation"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"113236","DOI":"10.1016\/j.physbeh.2020.113236","volume":"229","author":"C Yang","year":"2021","unstructured":"Yang C, Sui G, Li D, Wang L, Zhang S, Lei P, et al. Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice. Physiol Behav. 2021;229:113236.","journal-title":"Physiol Behav"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/mp.2017.87","volume":"23","author":"M Kondo","year":"2018","unstructured":"Kondo M, Koyama Y, Nakamura Y, Shimada S. A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects. Mol Psychiatry. 2018;23:833\u201342.","journal-title":"Mol Psychiatry"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biopsych.2018.12.014","volume":"86","author":"S Deyama","year":"2019","unstructured":"Deyama S, Bang E, Kato T, Li XY, Duman RS. Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor. Biol Psychiatry. 2019;86:143\u201352.","journal-title":"Biol Psychiatry"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"112844","DOI":"10.1016\/j.bbr.2020.112844","volume":"394","author":"S Deyama","year":"2020","unstructured":"Deyama S, Kaneda K. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice. Behav Brain Res. 2020;394:112844.","journal-title":"Behav Brain Res"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopsych.2009.10.018","volume":"67","author":"O Malkesman","year":"2010","unstructured":"Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G, et al. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry. 2010;67:864\u201371.","journal-title":"Biol Psychiatry"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/nprot.2009.141","volume":"4","author":"AH Macbeth","year":"2009","unstructured":"Macbeth AH, Edds JS, Young WS 3rd. Housing conditions and stimulus females: A robust social discrimination task for studying male rodent social recognition. Nat Protoc. 2009;4:1574\u201381.","journal-title":"Nat Protoc"},{"key":"1943_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.physbeh.2005.10.002","volume":"87","author":"Y Muroi","year":"2006","unstructured":"Muroi Y, Ishii T, Komori S, Nishimura M. A competitive effect of androgen signaling on male mouse attraction to volatile female mouse odors. Physiol Behav. 2006;87:199\u2013205.","journal-title":"Physiol Behav"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ijnp\/pyx023","volume":"20","author":"S Deyama","year":"2017","unstructured":"Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, Ide S, Satoh M, et al. Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway. Int J Neuropsychopharmacol. 2017;20:575\u201384.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","volume":"138","author":"S Deyama","year":"2018","unstructured":"Deyama S, Shimoda K, Ikeda H, Fukuda H, Shuto S, Minami M. Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice. J Pharm Sci. 2018;138:86\u201388.","journal-title":"J Pharm Sci"},{"key":"1943_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","volume":"235","author":"S Deyama","year":"2018","unstructured":"Deyama S, Shimoda K, Suzuki H, Ishikawa Y, Ishimura K, Fukuda H, et al. Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23. Psychopharmacol. 2018;235:329\u201336.","journal-title":"Psychopharmacol"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/npp.2013.128","volume":"38","author":"RJ Liu","year":"2013","unstructured":"Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology. 2013;38:2268\u201377.","journal-title":"Neuropsychopharmacology."},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1038\/mp.2017.220","volume":"23","author":"T Kato","year":"2018","unstructured":"Kato T, Fogaca MV, Deyama S, Li XY, Fukumoto K, Duman RS. BDNF release and signaling are required for the antidepressant actions of GLYX-13. Mol Psychiatry. 2018;23:2007\u201317.","journal-title":"Mol Psychiatry"},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/jcp.24607","volume":"229","author":"Y Wang","year":"2014","unstructured":"Wang Y, Wang W, Li D, Li M, Wang P, Wen J, et al. IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B\/PI3K-AKT-mTOR pathway. J Cell Physiol. 2014;229:1618\u201329.","journal-title":"J Cell Physiol"},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1120972","volume":"311","author":"O Berton","year":"2006","unstructured":"Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864\u20138.","journal-title":"Science."},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/bja\/aeh144","volume":"92","author":"Y Sato","year":"2004","unstructured":"Sato Y, Kobayashi E, Hakamata Y, Kobahashi M, Wainai T, Murayama T, et al. Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice. Br J Anaesth. 2004;92:859\u201364.","journal-title":"Br J Anaesth"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.08.001","volume":"276","author":"E Szczesny","year":"2014","unstructured":"Szczesny E, Basta-Kaim A, Slusarczyk J, Trojan E, Glombik K, Regulska M, et al. The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: The possible role of suppressors of cytokine signaling proteins. J Neuroimmunol. 2014;276:37\u201346.","journal-title":"J Neuroimmunol"},{"key":"1943_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2011.03.034","volume":"145","author":"P Cao","year":"2011","unstructured":"Cao P, Maximov A, Sudhof TC. Activity-dependent IGF-1 exocytosis is controlled by the Ca(2+)-sensor synaptotagmin-10. Cell. 2011;145:300\u201311.","journal-title":"Cell."},{"key":"1943_CR36","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1073\/pnas.1806820116","volume":"116","author":"A Pristera","year":"2019","unstructured":"Pristera A, Blomeley C, Lopes E, Threlfell S, Merlini E, Burdakov D, et al. Dopamine neuron-derived IGF-1 controls dopamine neuron firing, skill learning, and exploration. Proc Natl Acad Sci USA. 2019;116:3817\u201326.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1943_CR37","doi-asserted-by":"publisher","unstructured":"Tu X, Jain A, Decker H, Yasuda R. Local autocrine signaling of IGF1 synthesized and released by CA1 pyramidal neurons regulates plasticity of dendritic spines. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.04.08.439065. 2021.","DOI":"10.1101\/2021.04.08.439065"},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/0306-4522(92)90193-6","volume":"46","author":"C Bondy","year":"1992","unstructured":"Bondy C, Werner H, Roberts CT Jr, LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience. 1992;46:909\u201323.","journal-title":"Neuroscience."},{"key":"1943_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0306-4522(93)90303-W","volume":"53","author":"WH Lee","year":"1993","unstructured":"Lee WH, Michels KM, Bondy CA. Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II. Neuroscience. 1993;53:251\u201365.","journal-title":"Neuroscience."},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fnagi.2017.00365","volume":"9","author":"JL Labandeira-Garcia","year":"2017","unstructured":"Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B, Rodr\u00edguez-Perez AI. Insulin-like growth factor-1 and neuroinflammation. Front Aging Neurosci. 2017;9:365.","journal-title":"Front Aging Neurosci"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"172870","DOI":"10.1016\/j.pbb.2020.172870","volume":"190","author":"Y Wei","year":"2020","unstructured":"Wei Y, Chang L, Hashimoto K. A historical review of antidepressant effects of ketamine and its enantiomers. Pharm Biochem Behav. 2020;190:172870.","journal-title":"Pharm Biochem Behav"},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1523\/JNEUROSCI.20-08-02926.2000","volume":"20","author":"E Carro","year":"2000","unstructured":"Carro E, Nu\u00f1ez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci. 2000;20:2926\u201333.","journal-title":"J Neurosci"},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jneuroim.2006.06.014","volume":"179","author":"RH McCusker","year":"2006","unstructured":"McCusker RH, McCrea K, Zunich S, Dantzer R, Broussard SR, Johnson RW, et al. Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. J Neuroimmunol. 2006;179:186\u201390.","journal-title":"J Neuroimmunol"},{"key":"1943_CR44","doi-asserted-by":"publisher","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science. 2019;364:eaat8078.","journal-title":"Science"},{"key":"1943_CR45","doi-asserted-by":"publisher","first-page":"e0133","DOI":"10.1523\/ENEURO.0133-15.2016","volume":"3","author":"V Phoumthipphavong","year":"2016","unstructured":"Phoumthipphavong V, Barthas F, Hassett S, Kwan AC. Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex. eNeuro. 2016;3:e0133\u201315.2016.","journal-title":"eNeuro."},{"key":"1943_CR46","doi-asserted-by":"publisher","first-page":"e67267","DOI":"10.7554\/eLife.67267","volume":"10","author":"LE Maglio","year":"2021","unstructured":"Maglio LE, Noriega-Prieto JA, Maroto IB, Martin-Cortecero J, Munoz-Callejas A, Callejo-Mostoles M, et al. IGF-1 facilitates extinction of conditioned fear. Elife. 2021;10:e67267.","journal-title":"Elife."},{"key":"1943_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.10634","volume":"73","author":"CM Cheng","year":"2003","unstructured":"Cheng CM, Mervis RF, Niu SL, Salem N Jr., Witters LA, Tseng V, et al. Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res. 2003;73:1\u20139.","journal-title":"J Neurosci Res"},{"key":"1943_CR48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopsych.2015.08.028","volume":"80","author":"G Della Sala","year":"2016","unstructured":"Della Sala G, Putignano E, Chelini G, Melani R, Calcagno E, Michele Ratto G, et al. Dendritic spine instability in a mouse model of CDKL5 disorder Is rescued by insulin-like growth factor 1. Biol Psychiatry. 2016;80:302\u201311.","journal-title":"Biol Psychiatry"},{"key":"1943_CR49","first-page":"1477","volume":"83","author":"JL Thompson","year":"1998","unstructured":"Thompson JL, Butterfield GE, Gylfadottir UK, Yesavage J, Marcus R, Hintz RL, et al. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab. 1998;83:1477\u201384.","journal-title":"J Clin Endocrinol Metab"},{"key":"1943_CR50","unstructured":"Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. 3rd ed. Burlington, MA: Elsevier. 2007."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01943-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01943-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01943-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:28:26Z","timestamp":1669213706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01943-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-01943-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"18 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}